Mark O'Rourke

7PUBLICATIONS
40CO-AUTHORS
Preventative health careMolecular targetsSocial epidemiologyRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 16, 2022
Replace the advance directive with a patient activation approach to serious illness communication.

Mark Allen O'Rourke, Jamie S Myers, Frank L Meyskens

|Sep 27, 2022
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced <i>BRAF</i>-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134.

Michael B Atkins, Sandra J Lee, Bartosz Chmielowski

|Aug 18, 2021
Randomized Phase III Trial Evaluating Radiation Following Surgical Excision for Good-Risk Ductal Carcinoma In Situ: Long-Term Report From NRG Oncology/RTOG 9804.

Beryl McCormick, Kathryn A Winter, Wendy Woodward

|Jul 13, 2021
Association of Fatigue and Outcomes in Advanced Cancer: An Analysis of Four SWOG Treatment Trials.

Julia Mo, Amy K Darke, Katherine A Guthrie

|Jul 10, 2021
Reply Physician Tolerance of Uncertainty.

Mark O'Rourke, Lauren A Fowler, Matthew Frances Hudson

Pageof 2